The company has developed 3 generations of products: streptokinase, urokinase and tPA. The company has now developed 3d generation tPA by genetic engineering and claims a better security of their product compared to imported products. GMP certification and drug approval have been issued.
China Bio news release, Feb. 17, 2015
Guangzhou Recomgen Biotech Co. develops first Chinese single-bolus thrombolytic agent